What the new Canada guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 2 of 4 of this archive, newest first.
The evidence base is thin and the document says so, which is to its credit.
Reported from the sessions, and from the two hours afterwards.
Reported from the analysis, not from a warning notice.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The observation that closes a facility is rarely the dramatic one.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
The supplier has not disputed the finding. It has not explained the gap either.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
The evidence base is thin and the document says so, which is to its credit.
Follow the resin, not the catalogue.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
Efficacy was never the question in this appraisal. Duration of treatment was.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Follow the resin, not the catalogue.